Literature DB >> 8142465

Purification of selenoprotein P from human plasma.

B Akesson1, T Bellew, R F Burk.   

Abstract

Selenoprotein P was partially purified (> 1000-fold) from human plasma in four chromatographic steps using 75Se-labeled selenoprotein P secreted by HepG2 cells in culture as a marker. The purified preparation was injected into mice and monoclonal antibodies, which precipitated the labeled protein, were generated. Neither of two different monoclonal antibodies had cross-reactivity with plasma from five animal species. Antibodies were coupled to agarose, and selenoprotein P was purified from human plasma by immunoaffinity chromatography followed by chromatography on heparin agarose. With two different matrix-bound monoclonal antibodies, the purification procedure gave two bands on SDS-PAGE with mobilities corresponding to 61 and 55 kDa. Both bands stained for carbohydrate and showed increased electrophoretic mobility after enzymatic deglycosylation. Immunoaffinity chromatography removed approx. one-third of the selenium from plasma or 0.4 mumol Se/l at a total selenium concentration of 1.1 mumol/l, indicating that selenoprotein P constituted this proportion of total plasma selenium in healthy US blood donors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142465     DOI: 10.1016/0167-4838(94)90014-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Authors:  S Lepage; D Bonnefont-Rousselot; E Bruckert; B Bourely; M C Jaudon; J Delattre; U Assogba
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 2.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

3.  Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.

Authors:  B-J Ko; S M Kim; K H Park; H S Park; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-03-18       Impact factor: 5.095

4.  Cross sectional and longitudinal study on selenium, glutathione peroxidase, smoking, and occupational exposure in coal miners.

Authors:  R Nadif; M P Oryszczyn; M Fradier-Dusch; G Hellier; J P Bertrand; Q T Pham; F Kauffmann
Journal:  Occup Environ Med       Date:  2001-04       Impact factor: 4.402

5.  Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial.

Authors:  Rachel Hurst; Charlotte N Armah; Jack R Dainty; Dave J Hart; Birgit Teucher; Andrew J Goldson; Martin R Broadley; Amy K Motley; Susan J Fairweather-Tait
Journal:  Am J Clin Nutr       Date:  2010-02-24       Impact factor: 7.045

6.  Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1.

Authors:  Colleen Rock; Philip J Moos
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-09-09       Impact factor: 4.006

Review 7.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

8.  Selenoprotein P regulation by the glucocorticoid receptor.

Authors:  Colleen Rock; Philip J Moos
Journal:  Biometals       Date:  2009-12       Impact factor: 2.949

9.  Domain structure of bi-functional selenoprotein P.

Authors:  Yoshiro Saito; Noriko Sato; Masaki Hirashima; Gen Takebe; Shigeharu Nagasawa; Kazuhiko Takahashi
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 10.  Selenoprotein P-expression, functions, and roles in mammals.

Authors:  Raymond F Burk; Kristina E Hill
Journal:  Biochim Biophys Acta       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.